A new study shows that the inhalation of cannabis could be linked to improvements and better quality of life for those with ulcerative colitis. The trial, titled “Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial,” was published in the PLoS One journal and outlines the effects of high-THC cannabis use on ulcerative colitis.
The study was carried out by researchers in Israel, who looked at how inhaling herbal cannabis impacted ulcerative colitis patients over a period of eight weeks, with continued, steady, use. It used a double-blind, randomized, placebo-controlled method to ensure the data would be accurate and unbiased, and the patients would not know what they were getting. The cannabis inhaled contained either 16 percent THC or virtually no THC. The patients also kept taking standard medication.
“Survey data indicate that cannabis use is relatively common among patients with inflammatory bowel diseases and observational data has previously shown that cannabis may alleviate symptoms of certain IBD-related disorders, like Crohns,” the study explained regarding the meanings behind looking